Histopathological findings of prostatic autopsy in a sample of over 50 years old men in Baghdad, Iraq

Ali Hussein Abid, Ehab Jasim Mohammad, Alaa Abdulqader Abdulrazaq


Background: Incidental carcinoma of the prostate is very important is one of the major life-threatening condition for men at all ages. The incidence was found to increase with age. The aim of this study was to evaluate prostatic autopsy samples from Iraqi men over 50 years of age.

Methods: 100 autopsy samples of whole prostate were collected from the Institute of Forensic Medicine in Baghdad. All the autopsy cases over 50 years of age died from causes unrelated to prostatic disease.

Results: Age ranges from 50-80 years and the mean age was 59.3 years. Benign prostatic hyperplasia was the common pathological finding (92%). Forty-eight cases of benign prostatic hyperplasia were associated with chronic non-specific prostatitis (CNP), 6 cases were associated with low grade prostatic intraepithelial neoplasia and 2 cases with infarction and 6 cases of low grade prostatic intraepithelial neoplasia. Prostatic adenocarcinoma was detected in 6% of the cases. The mean weight was 39.9gm. The mean ellipsoid volume was 34.9cm3. The mean spheroid volume was 36.1cm3. The majority of benign prostatic hyperplasia cases were found in the 6th decade.

Conclusions: From the present study, we can conclude that the majority of cases were in the 6th decade, benign prostatic hyperplasia was the most common finding, the most common association with benign prostatic hyperplasia was chronic nonspecific prostatitis, a low frequency of prostatic carcinoma and it was not associated with benign prostatic hyperplasia.


Adenocarcinoma, Colorectal, Carcinoma, Colonoscopy, Retrospective

Full Text:



Liu X, Tang J, Yang J, Zhang Y, Shi H. An autopsy specimen study of benign hyperplastic nodules in the peripheral zone of the prostate. National J Androl. 2008;14(4):307-10.

Erinomo O, Anunobi C, Orah N. Autopsy study of prostatic weight and lesions in LUTH: a 12-month prospective study. Nigerian Quarterly J Hospital Med. 2013;23(2):85-9.

Eylert M, Persad R. Management of prostate cancer. British J Hospital Med. 2012;73(2).

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, et al. Over diagnosis and overtreatment of prostate cancer. European Urol. 2014;65(6):1046-55.

Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J National Cancer Institute. 2007;99(19):1484-9.

Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol. 2007;177(2):444-9.

Powell IJ, Bock CH, Ruterbusch JJ, Sakr W. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010;183(5):1792-7.

Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J National Cancer Institute. 2013;105(14):1050-8.

Bell KJ, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. International J Cancer. 2015;137(7):1749-57.

Delongchamps N, De la Roza G, Chandan V, Jones R, Threatte G, Jumbelic M, et al. Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen. Prostate Cancer Prostatic Dis. 2009;12(2):137.

Kido M, Hitosugi M, Ishii K, Kamimura S, Joh K. Latent prostate cancer in Japanese men who die unnatural deaths: a forensic autopsy study. Prostate. 2015;75(9):917-22.

Alsinnawi M, Loftus B, Flynn R, McDermott T, Grainger R, Thornhill J. The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens. International Urol Nephrol. 2012;44(6):1705-10.

Morgentaler A. Testosterone therapy for men at risk for or with history of prostate cancer. Current Treatment Options Oncol. 2006;7(5):363-9.

Delongchamps NB, de la Roza G, Chandan V, Jones R, Sunheimer R, Threatte G, et al. Evaluation of prostatitis in autopsied prostates is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol. 2008;179(5):1736-40.

Sánchez‐Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate. 2003;54(3):238-47.

Zhang Y, Nojima S, Nakayama H, Jin Y, Enza H. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate. Oncol Reports. 2003;10(1):207-11.

Ono Y, Ozawa M, Suzuki K, Okazaki H, Tamura Y, Suzuki T, et al. Autopsy findings of patients with urological neoplasms. Int J Clin Oncol. 2002;7(5):0301-5.

Epsi E, Sultana S, Mannan S, Azam A, Choudhury S, Ahmed Z, et al. Study of Prostatic Volume and its Variations in Different Age Groups of Bangladeshi Cadaver. Mymensingh Medical Journal: MMJ. 2016;25(4):615-9.

Yokoyama S, Fukuhara S, Imazu T, Hara T, Yamaguchi S, Adachi S. Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report. Hinyokika kiyo Acta Urologica Japonica. 2007;53(7):485-7.

Klint A, Engholm G, Storm HH, Tryggvadottir L, Gislum M, Hakulinen T, et al. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncologica. 2010;49(5):578-607.

Hill C, Laplanche A. Prostate cancer: the evidence weighs against screening. Presse medical (Paris, France: 1983). 2010;39(9):859-64.

Trivunic S, Budakov P, Vuckovic N, Zivojinov M. Morphological parameters of prostatic adenocarcinoma. Medicinski Pregled. 2007;60(11,12):549-52.